Title : PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.

Pub. Date : 2013 Nov

PMID : 23769634






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additionally, combination therapy with PKI-587 and sorafenib caused significantly more inhibition than monotherapy in HuH7, PLC, and LCSC. Sorafenib heparan sulfate proteoglycan 2 Homo sapiens